Mindray
| Company type | Public |
|---|---|
| Industry | Medical instrumentation |
| Founded | 1991 |
| Founder | Li Xiting, Xu Hang, Cheng Minghe, and others |
| Headquarters | Shenzhen , China |
Area served | Worldwide |
| Products | Medical devices and accessories (Patient Monitoring & Life Support, In-Vitro Diagnostic Products, Medical Imaging Systems) |
Mindray Medical International Limited () is a global Chinese enterprise specializing in medical instrumentation, with its headquarters located in Shenzhen, Guangdong. The company designs and manufactures medical devices and related accessories catering to both human healthcare and veterinary medicine. Its operations are divided into three primary sectors: Patient Monitoring & Life Support, In-Vitro Diagnostic Products, and Medical Imaging Systems. In 2008, Mindray was acknowledged as the leading medical device producer within China.
History
Established in 1991 in Shenzhen by seven former employees of Anke, including notable founders such as Li Xiting (), Xu Hang (), and Cheng Minghe (), Mindray initially grew by providing domestically produced patient monitoring, diagnostic, and imaging equipment. The company now maintains 41 subsidiaries and branch offices spread over 31 countries, alongside 32 branches within China. Mindray entered the NYSE in September 2006, withdrew from it in March 2016 to facilitate a re-entry into China's A-Share market, and successfully re-listed on the Shenzhen Stock Exchange in October 2018.
Towards the end of 2018, Mindray encountered criticism after retracting employment offers extended to 254 university graduates due to shifting economic conditions; however, these offers were reinstated in early 2019 as part of the company’s commitment to corporate social responsibility.
In January 2019, Mindray collaborated with Korle Bu Teaching Hospital in Ghana, providing a SAL 6000 analyzer aimed at improving the efficiency of laboratory testing locally.
Divisions
The Patient Monitoring & Life Support segment is responsible for the development and production of multi-parameter patient monitors, biotelemetry devices, anesthesia delivery systems, defibrillators, ECG equipment, pulse oximeters, hospital beds, mounting solutions, and IT platforms. To expand its international footprint beyond China, Mindray acquired Datascope Corporation’s Patient Monitoring division in 2008 for $209 million.
Within the In-Vitro Diagnostic segment, the company supplies diagnostic tools and reagents for clinical analysis of blood, urine, and other biological fluids. The portfolio includes semi-automated and fully automated hematology and biochemistry analyzers, reagents, microplate readers, and washers tailored for use in laboratories, clinics, and hospitals.